Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 156 (3) , 662-675.e7
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs (I01BX001179, 1IK6BX003787)
- National Institutes of Health (R01CA131225)
- University of Miami
This publication has 50 references indexed in Scilit:
- Aurora Kinase A Is a Prognostic Marker in Colorectal AdenocarcinomaJournal of Pathology and Translational Medicine, 2017
- Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patientsJournal of Ovarian Research, 2016
- Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotypeNature Communications, 2016
- A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma TumorigenesisCancer Cell, 2015
- Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinomaBMC Cancer, 2015
- Aurora Kinase A Promotes Inflammation and Tumorigenesis in Mice and Human Gastric NeoplasiaGastroenterology, 2013
- Functions and regulation of the 70 kDa ribosomal S6 kinasesThe International Journal of Biochemistry & Cell Biology, 2011
- New Strategies for Treatment of KRAS Mutant Metastatic Colorectal CancerClinical Cancer Research, 2010
- Suppression of Aurora-A oncogenic potential by c-Myc downregulationExperimental & Molecular Medicine, 2010
- Aurora-A overexpression enhances cell-aggregation of Ha-rastransformants through the MEK/ERK signaling pathwayBMC Cancer, 2009